Skip to contentSkip to footer
      employer cover photo
      employer logo
      employer logo

      AutoGenomics

      Part of Prescient Medicine

      Is this your company?

      Find the right fit for you - faster

      Get tailored insights about working at AutoGenomics in one quick step.

      AutoGenomics Snapshot

      2.7
      based on 20 ratings

      15% would recommend to a friend

      avatar

      Keri Donaldson

      Not enough data to show CEO approval

      1 OfficeLocations
      Description AutoGenomics is mapping the road to the future of medicine. The company developed a genetic testing system called INFINITI that scans DNA samples for genetic disorders, infectious diseases, cancer, and pharmacogenetics (a patient's genetic likeliness to have an adverse reaction to a drug). AutoGenomics found about 25 uses for the INFINITI, but only four have been approved by the FDA for diagnostic use -- testing for sensitivity to the popular blood thinner warfarin, screening for the risk of developing cystic fibrosis or cervical cancer (for women with HPV), and testing for a gene that blocks common drugs from working. AutoGenomics was founded in 1999 as Neuron Technologies and applied to go public in 2008.

      Life at AutoGenomics

      Related searches: AutoGenomics jobs | AutoGenomics salaries | AutoGenomics benefits | AutoGenomics interviews
      CompaniesAbout AutoGenomics

      Glassdoor gives you an inside look at what it's like to work at AutoGenomics, including salaries, reviews, office photos, and more. This is the AutoGenomics company profile. All content is posted anonymously by employees working at AutoGenomics.